Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 4,187

Document Document Title
WO/2021/065350A1
Provided are: a radiation-sensitive resin composition having excellent performance in terms of sensitivity, LWR, etc., in an exposure step even when a next-generation exposure technique is applied; and a method for forming a resist patte...  
WO/2021/052353A1
The present invention relates to the technical field of enzyme inhibitors, and relates in particular to a hydroxamic acid derivative, a preparation method therefor and an application thereof. The hydroxamic acid group in the hydroxamic a...  
WO/2021/016720A1
The present technology generally relates to a triploid Cannabis plant, triploid Cannabis seeds and to methods for generating such triploid Cannabis plant. The methods comprise crossing a tetraploid Cannabis plant with a diploid Cannabis ...  
WO/2021/012046A1
There are provided compositions comprising at least one compound chosenfrom compound of formula (I), compound of formula (II), compound of formula (III) and compound of formula (IV) and a cannabinoid extract.  
WO/2021/001044A1
Object of the present invention is an improved process for the preparation of key intermediates for the synthesis of Eltrombopag, passing through/using intermediate 5'-Chloro-2'-hydroxy[1,1'-biphenyl]-3-carboxylic acid alkaline metal sal...  
WO/2021/000053A1
The present invention provides cannabinoid derivatives, a pharmaceutical composition comprising said derivative and a method of using said derivatives in treating or preventing a disease associated with cannabinoid receptors. The claimed...  
WO/2020/263229A1
The present invention provides a composition comprising an acidic formulation containing β-hydroxy-β-methylbutyrate (HMB), preferably in the free acid form, Vitamin D and a stabilizing excipient, wherein the Vitamin D is stabilized aga...  
WO/2020/262452A1
The present invention addresses the problem of providing a novel hydrogen storage material containing a metal organic structure capable of effectively storing hydrogen. Hydrogen can be effectively stored using a hydrogen storage materi...  
WO/2020/262451A1
The invention addresses the problem that metal-organic frameworks have conventionally only been produced with terephthalic acids having a limited range of substituents even though the amount and type of gas stored thereby can vary depend...  
WO/2020/253076A1
Discloses the use of a hydroxycarboxylic acid compound for controlling plant diseases by fungi and oomycetes, wherein the hydroxycarboxylic acid compound is selected from compounds of formulas (I), (II), (III) and (IV), as well as isomer...  
WO/2020/248076A1
Disclosed are methods for separating, recovering, and purifying cannabidiolic acid (CBDA) salts from an organic solvent solution comprising a mixture of cannabinoids. The methods comprise solubilizing the mixture of cannabinoids in C5-C7...  
WO/2020/183173A3
The present invention relates to compounds of formula I: in which A1-A7 and R1 to R5 are defined herein, for use in the treatment of a condition or disease which is alleviated by the activation of retinoic acid receptors (RAR). The inven...  
WO/2020/233502A1
Disclosed is a method for preparing cannabidiol and analogues thereof; the method is implemented by means of reacting a resorcinol derivative with menthyl-2,8-dien-1-ol or a derivative thereof. The method of the present invention has adv...  
WO/2020/230820A1
The purpose of the present invention is to produce a high-quality metal-organic structure in a short period of time. The method for producing a metal-organic structure according to the present invention comprises applying centrifugal for...  
WO/2020/203444A1
A compound which has, between end groups arranged at both ends and each having a reactive group, a first structure wherein an aromatic ring group, an ether oxygen atom, a methylene group, an aromatic ring group, a methylene group, an eth...  
WO/2020/181395A1
The present application relates to a rinse-off composition comprising an oil phase and an aqueous surfactant matrix, wherein one or more active agents are dissolved in one or more non-polar, water-immiscible solvents, and the oil phase i...  
WO/2020/179769A1
The present invention addresses the problem of providing a novel industrially-suitable method for producing 4-hydroxy-2-methyl benzoate. As a solution, provided is a 4-hydroxy-2-methyl benzoate production method characterized by performi...  
WO/2020/168421A1
The invention provides cyclodextrin inclusion complexes of cannabis extracts, cannabinoids and cannabis terpenes, and methods of making such complexes. The cyclodextrin inclusion complexes include a host and guest compounds. The host may...  
WO/2020/162156A1
The present invention provides a compound which enables a light emitting element to have excellent luminance life. A compound which is represented by formula (1). (In the formula, n represents an integer of from 2 to 20 (inclusive); ...  
WO/2020/156857A1
The present invention relates to a process for the production of oxidized wood products, comprising step a) reacting chips of one or more wood products in a basic solution at a p H between 8 and 14 under an oxygen atmosphere at a pressur...  
WO/2020/160201A1
A method for purification of a biphenol tetraacid composition includes contacting the biphenol tetraacid composition with a solvent including a C1-6 alcohol to form a slurry and isolating the purified biphenol tetraacid from the slurry. ...  
WO/2020/154581A1
The present disclosure relates to co-crystals of Fedovapagon, processes for preparation thereof as well as a pharmaceutical composition including the same.  
WO/2020/141141A1
The invention relates to novel cocrystals of (R)-Baclofen and processes for preparation thereof, and in particular to cocrystals of (R)-Baclofen with cinnamic acid, benzoic acid, salicylic acid and ferulic acid. It also refers to pharmac...  
WO/2020/124220A1
Provided are pharmaceutical compositions comprising cannabis such that when combusted produces cannabidiolic acid (CBDA) for inhalation. Also provided are pharmaceutical composition for inhalation by a subject comprising tetrahydrocannab...  
WO/2020/117654A1
The invention is directed at esylate and salicylate salts of cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)prop -2-enylamine and their pharmaceutical composition. The invention is also directed at the use esylate and salicylate...  
WO/2020/102952A1
Applications of a diphenylpropenone compound of general formula (I), or a stereoisomer thereof, or a geometric isomer thereof, or a tautomer thereof, or a solvate thereof, or a salt acceptable for feed in the preparation of an animal fee...  
WO/2020/095017A1
Molecular complexes comprising 3,6-dichloro-2-methoxybenzoic acid (dicamba) and a compound selected from the group of triazine herbicides are described, together with compositions comprising such molecular complexes, and methods of their...  
WO/2020/084427A1
A system and a method for extracting one or more active compounds from a cannabis biomass are disclosed. The method comprises obtaining a raw biomass of cannabis plant. A prepared biomass may be obtained from the raw biomass and may be m...  
WO/2020/074964A1
The present disclosure relates to compounds of the general formula (I): wherein R1, R2, R3, R4, R5, R6, and R7 may be chosen from different substituents; n is 0, 1, or 2; and X is a hydroxymethyl or a carboxylic acid or a derivative ther...  
WO/2020/044119A3
Described herein are cannabinoid formulations in combination with lavender and/or a lavender extract for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need the...  
WO/2020/050368A1
The purpose of the present invention is to provide: a method for preparing a Vilsmeier reagent, that can be carried out safely, easily, and at a low cost; and a method for producing an aromatic aldehyde or an aromatic ketone, a carboxyli...  
WO/2020/044121A1
Described herein are cannabinoid formulations in combination with phenylalanine for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturin...  
WO/2020/044123A1
Described herein are cannabinoid formulations in combination with Boswellia extract for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufact...  
WO/2020/044116A1
Described herein are cannabinoid formulations in combination with curcumin for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturing ora...  
WO/2020/044118A1
Described herein are cannabinoid formulations for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof.  
WO/2020/038238A1
Provided is a nicotine eutectic crystal, which is obtained by self-assembling nicotine and 2,6-dihydroxybenzoic acid in a molar ratio of 1 : 1 to 1 : 5 and has a melting point of 159ºC-163ºC. Further provided are a preparation method f...  
WO/2020/028992A1
The invention relates to methods of producing extracts from cannabis plant material, where the extracts comprise cannabinoids and terpenes. The methods comprise extracting fresh or dried plant material with a cold organic solvent. The me...  
WO/2020/022441A1
The present invention addresses the problem of providing an antiviral composition that shows a high solubility of an antiviral component and has an excellent antiviral activity. The present invention further addresses the problem of prov...  
WO/2020/014776A1
An oral dispersible film composition comprising at least one active ingredient and a film forming agent, as well as a method of manufacture of same. The oral dispersible film composition can be free of gum resin, and can be utilized to a...  
WO/2019/242765A1
The present invention provides a compound represented by the formula (I) or an optical isomer thereof, and a tautomer, a pharmaceutically acceptable salt, a prodrug, a hydrate, or a solvate. The various deuterated compounds and salts and...  
WO/2019/217536A9
Compositions that include a bupivacaine salt are provided. The compositions may include bupivacaine linoleate, bupivacaine linolenate or bupivacaine laurate, at least one thermosensitive polymer, and at least one mucoadhesive or dermoadh...  
WO/2019/227202A1
Disclosed are pharmaceutical salts and co-crystals of pentoxifylline, clonidine and linsidomine with caffeic acid, protocatechuic acid or α-lipoic acid, and method for preparing thereof. Also disclosed are topical compositions comprisin...  
WO/2019/223186A1
The invention relates to the technical field of co-crystal pesticides, and in particular relates to a triazole sulcotrione-salicylic acid co-crystal, a preparation method thereof, and an application thereof. The triazole sulcotrione-sali...  
WO/2019/186284A3
This invention relates to novel products of compressed Cannabis flower for medicinal and/or recreational use, and for methods of making such products.  
WO/2019/217536A1
Compositions that include a bupivacaine salt are provided. The compositions may include bupivacaine linoleate, bupivacaine linolenate or bupivacaine laurate, at least one thermosensitive polymer, and at least one mucoadhesive or dermoadh...  
WO/2019/210401A1
A solvent free method of concentrating naturally occurring 2 - carboxylic acid cannabinoids contained in fresh Cannabis: THCA (Tetrahydrocannabinolic acid), CBDA (Cannabidiolic acid), CBNA (Cannabinol acid), CBGa (Cannabigerol acid), CBC...  
WO/2019/212233A1
The present invention relates to a method for preparing 4,4'-dihydroxy-[1,1'-biphenyl-3,3'-dicarboxylic acid], the method comprising a step for preparing a compound represented by chemical formula 1 by reacting a compound represented by ...  
WO/2019/196379A1
Disclosed is a method for catalyzing selective hydrogenolysis of lignin by a nickel-base material loaded by zirconium phosphate. The method is used for preparing a monophenol chemical substance by means of hydrogenolysis. The method comp...  
WO/2019/190823A1
The application relates to pharmaceutically acceptable salts of [3-(4- {2-butyl-l-[4-(4-chloro-phenoxy)-phenyl]-lH-imidazol-4-yl}-p henoxy) -propyl]-diethylamine (Azeliragon) useful in the treatment of RAGE mediated diseases such as Alzh...  
WO/2019/180505A1
Cannabis pods comprising a defined dose of cannabis and methods for making said pods. This method comprises milling or grinding the cannabis, passing it through a mesh or sieve, determining the desired amount of cannabinoid, and encapsul...  

Matches 1 - 50 out of 4,187